# OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Canonical URL: https://biopharmsignal.com/news/OPKO/opko-health-and-entera-bio-expand-partnership-to-advance-first-in-class-oral-long-acting-pth-tablet-for-patients-with-hypoparathyroidism
Ticker: OPKO
Company: Opko
Source: Opko
Published: 2026-02-04 13:00 EST
Original Source URL: https://www.opko.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-12 12:00 EST — [OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies](https://biopharmsignal.com/news/OPKO/opko-health-s-modex-therapeutics-will-present-data-demonstrating-in-vivo-car-t-cell-generation-and-deep-b-cell-depletion-in-preclinical-studies) — Source: Opko
- 2026-04-30 12:00 EST — [BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform](https://biopharmsignal.com/news/OPKO/bioreferencer-launches-bioreference-directtm-expanding-access-to-consumer-initiated-diagnostic-testing-through-a-fully-integrated-digital-platform) — Source: Opko
- 2026-04-08 12:00 EST — [OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19](https://biopharmsignal.com/news/OPKO/opko-health-s-modex-therapeutics-initiates-clinical-trial-of-mdx2301-for-the-prevention-of-covid-19) — Source: Opko
- 2026-02-27 13:00 EST — [OPKO Health to Participate in the Jefferies Biotech on the Beach Summit](https://biopharmsignal.com/news/OPKO/opko-health-to-participate-in-the-jefferies-biotech-on-the-beach-summit) — Source: Opko
- 2026-02-26 21:05 EST — [OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results](https://biopharmsignal.com/news/OPKO/opko-health-reports-fourth-quarter-2025-business-highlights-and-financial-results) — Source: Opko
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)